Laure Sillis

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Omega-3 fatty acid supplement use in Belgian pregnant women: universal practice or selective use?

Omega-3 fatty acid supplement use in Belgian pregnant women: universal practice or selective use?

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: June 23, 2026

Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based review.

Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based review.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Medication, Vaccine, and Folic Acid Use Among Pregnant Women in Belgium: Insights from the BELpREG Cohort.

Medication, Vaccine, and Folic Acid Use Among Pregnant Women in Belgium: Insights from the BELpREG Cohort.

Journal: Pharmacoepidemiology and drug safety

Published: November 09, 2025

Medications for Nausea and Vomiting of Pregnancy and the Risks for Adverse Birth Outcomes.

Medications for Nausea and Vomiting of Pregnancy and the Risks for Adverse Birth Outcomes.

Journal: Pharmacoepidemiology and drug safety

Published: August 22, 2025

Reliability of Self-Reported Maternal Health and Mother-Infant Outcome Data in Web-Based Questionnaires.

Reliability of Self-Reported Maternal Health and Mother-Infant Outcome Data in Web-Based Questionnaires.

Journal: Drug safety

Published: April 08, 2025

Metformin for the Prevention of Hyperemesis Gravidarum: An Observational Cohort Study.

Metformin for the Prevention of Hyperemesis Gravidarum: An Observational Cohort Study.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: February 28, 2025

Alcohol, Tobacco and Illicit Drug Use During Pregnancy in the Longitudinal BELpREG Cohort in Belgium Between 2022 and 2024.

Alcohol, Tobacco and Illicit Drug Use During Pregnancy in the Longitudinal BELpREG Cohort in Belgium Between 2022 and 2024.

Journal: Journal of clinical medicine

Published: December 04, 2024

Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium.

Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real-world data source on medication use in pregnancy in Belgium.

Journal: Pharmacoepidemiology and drug safety

Published: December 04, 2023

Development and design of the BELpREG registration system for the collection of real-world data on medication use in pregnancy and mother-infant outcomes.

Development and design of the BELpREG registration system for the collection of real-world data on medication use in pregnancy and mother-infant outcomes.

Journal: Frontiers in drug safety and regulation

Published: February 15, 2023

Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".

Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".

Journal: Journal of reproductive immunology

Published: May 06, 2022

Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative Analysis.

Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative Analysis.

Journal: International journal of environmental research and public health

Published: January 21, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026